Buy PASSAGE BIO Stock | PASG Stock Price & Latest News | Public.com
PASG

PASSAGE BIO

$0.00 (0.00%)Today
    View PASSAGE BIO (PASG) stock trends here

    About PASG

    Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine product...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.29
    -0.57
    -0.86
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.73

    Actual EPS
    Q2 2021

    Stats

    Market Cap$893,86M
    Volume1
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$38.23
    1 Year Low$12.10
    Open$17.45
    High$17.72
    Low$16.23

    Buy any stock with any amount of money.

    Download the App
    Download the app